The FDA has approved an immunotherapy combination therapy for adult patients with Bacillus Calmette-Guérin-naive, high-risk ...

Disease-free survival improved with durvalumab plus BCG induction/maintenance versus BCG alone, reducing recurrence/progression/death risk (HR 0.68; p=0.0154) with median DFS not reached. Eligibility ...

After nearly two decades of life-threatening illness, repeated complications, and organ failure, 33-year-old Briana Dery of ...

Joy Emeh is a professional health writer, editor, content strategist, and career development coach with up to four years of experience in the health writing space. She is interested in all things ...